These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 23384436)

  • 21. Proposal of a 2-tier histologic grading system for canine cutaneous mast cell tumors to more accurately predict biological behavior.
    Kiupel M; Webster JD; Bailey KL; Best S; DeLay J; Detrisac CJ; Fitzgerald SD; Gamble D; Ginn PE; Goldschmidt MH; Hendrick MJ; Howerth EW; Janovitz EB; Langohr I; Lenz SD; Lipscomb TP; Miller MA; Misdorp W; Moroff S; Mullaney TP; Neyens I; O'Toole D; Ramos-Vara J; Scase TJ; Schulman FY; Sledge D; Smedley RC; Smith K; W Snyder P; Southorn E; Stedman NL; Steficek BA; Stromberg PC; Valli VE; Weisbrode SE; Yager J; Heller J; Miller R
    Vet Pathol; 2011 Jan; 48(1):147-55. PubMed ID: 21062911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and prognostic value of c-kit and TP53 mutations in canine mast cell tumours.
    Vozdova M; Kubickova S; Fictum P; Fröhlich J; Jelinek F; Rubes J
    Vet J; 2019 May; 247():71-74. PubMed ID: 30971355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of P-glycoprotein, STAT3, phospho-STAT3 and KIT in spontaneous canine cutaneous mast cell tumours before and after prednisolone treatment.
    Teng SP; Hsu WL; Chiu CY; Wong ML; Chang SC
    Vet J; 2012 Aug; 193(2):551-6. PubMed ID: 22398132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytological grading of canine cutaneous mast cell tumours.
    Scarpa F; Sabattini S; Bettini G
    Vet Comp Oncol; 2016 Sep; 14(3):245-51. PubMed ID: 24717019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markers.
    Gil da Costa RM; Matos E; Rema A; Lopes C; Pires MA; Gärtner F
    BMC Vet Res; 2007 Aug; 3():19. PubMed ID: 17711582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of risk factors for canine mast cell tumors based on the Kiupel and Patnaik grading system among dogs with skin tumors.
    Martins AL; Carvalho FF; Mesquita JR; Gärtner F; Amorim I
    Open Vet J; 2021; 11(4):619-634. PubMed ID: 35070857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of Fibroblast Activating Protein and Correlation with Histological Grade, Mitotic Index and Ki67 Expression in Canine Mast Cell Tumours.
    Giuliano A; Dos Santos Horta R; Constantino-Casas F; Hoather T; Dobson J
    J Comp Pathol; 2017 Jan; 156(1):14-20. PubMed ID: 27889201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic and predictive significance of KIT protein expression and c-kit gene mutation in canine cutaneous mast cell tumours: A consensus of the Oncology-Pathology Working Group.
    Thamm DH; Avery AC; Berlato D; Bulman-Fleming J; Clifford CA; Hershey AE; Intile JL; Jones PD; Kamstock DA; Liptak JM; Pavuk A; Peauroi J; Powell R; Rissetto K; Valli VEO; Webster JD
    Vet Comp Oncol; 2019 Dec; 17(4):451-455. PubMed ID: 31264352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-kit as a prognostic and therapeutic marker in canine cutaneous mast cell tumours: From laboratory to clinic.
    Gil da Costa RM
    Vet J; 2015 Jul; 205(1):5-10. PubMed ID: 26021891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in the proteome of high-grade versus low-grade canine cutaneous mast cell tumours.
    Schlieben P; Meyer A; Weise C; Bondzio A; Einspanier R; Gruber AD; Klopfleisch R
    Vet J; 2012 Nov; 194(2):210-4. PubMed ID: 22578690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a modified proportional margins approach for surgical resection of mast cell tumors in dogs: 40 cases (2008-2012).
    Pratschke KM; Atherton MJ; Sillito JA; Lamm CG
    J Am Vet Med Assoc; 2013 Nov; 243(10):1436-41. PubMed ID: 24171373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. c-KIT messenger RNA and protein expression and mutations in canine cutaneous mast cell tumors: correlations with post-surgical prognosis.
    Giantin M; Vascellari M; Morello EM; Capello K; Vercelli A; Granato A; Lopparelli RM; Nassuato C; Carminato A; Martano M; Mutinelli F; Dacasto M
    J Vet Diagn Invest; 2012 Jan; 24(1):116-26. PubMed ID: 22362941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic accuracy of pre-treatment biopsy for grading cutaneous mast cell tumours in dogs.
    Shaw T; Kudnig ST; Firestone SM
    Vet Comp Oncol; 2018 Jun; 16(2):214-219. PubMed ID: 28857446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ki67/KIT double immunohistochemical staining in cutaneous mast cell tumors from Boxer dogs.
    Fonseca-Alves CE; Bento DD; Torres-Neto R; Werner J; Kitchell B; Laufer-Amorim R
    Res Vet Sci; 2015 Oct; 102():122-6. PubMed ID: 26412531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Canine mast cell tumours: a review of the pathogenesis, clinical features, pathology and treatment.
    Welle MM; Bley CR; Howard J; Rüfenacht S
    Vet Dermatol; 2008 Dec; 19(6):321-39. PubMed ID: 18980632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of mitotic index and Ki67 index in the prognostication of canine cutaneous mast cell tumours.
    Berlato D; Murphy S; Monti P; Stewart J; Newton JR; Flindall A; Maglennon GA
    Vet Comp Oncol; 2015 Jun; 13(2):143-50. PubMed ID: 23489679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours.
    Kiupel M; Webster JD; Miller RA; Kaneene JB
    J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):280-6. PubMed ID: 16050909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular proliferation in canine cutaneous mast cell tumors: associations with c-KIT and its role in prognostication.
    Webster JD; Yuzbasiyan-Gurkan V; Miller RA; Kaneene JB; Kiupel M
    Vet Pathol; 2007 May; 44(3):298-308. PubMed ID: 17491070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TSLC1 tumour-suppressor gene expression in canine mast cell tumours.
    Taylor F; Murphy S; Hoather T; Dobson J; Scase T
    Vet Comp Oncol; 2010 Dec; 8(4):263-72. PubMed ID: 21062408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retrospective outcome evaluation for dogs with surgically excised, solitary Kiupel high-grade, cutaneous mast cell tumours.
    Moore AS; Frimberger AE; Taylor D; Sullivan N
    Vet Comp Oncol; 2020 Sep; 18(3):402-408. PubMed ID: 31916687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.